Dow Up 1.30% Nasdaq Up 0.37%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
134.60 2.51(1.90%) Oct 30, 4:00PM EDT
Prev Close:132.08
Open:132.09
Bid:132.00 x 200
Ask:138.50 x 300
1y Target Est:157.56
Beta:1.09
Next Earnings Date: 4-Nov-14PCYC Earnings announcement
Day's Range:130.93 - 134.93
52wk Range:82.51 - 154.89
Volume:546,794
Avg Vol (3m):846,505
Market Cap:10.13B
P/E (ttm):120.28
EPS (ttm):1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PCYC

Comparison

Symbol% ChgMkt Cap
PCYCUp 1.90%10.13B
CTIC345.24M
MRK165.32B

Key Statistics

Forward P/E (1 yr):13,459.50
P/S (ttm):22.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.38
Quarterly EPS Est (Sep-14) :0.38
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2,213.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback